» Articles » PMID: 20299772

Participation in Genetic Testing Research Varies by Social Group

Overview
Specialties Genetics
Public Health
Date 2010 Mar 20
PMID 20299772
Citations 68
Authors
Affiliations
Soon will be listed here.
Abstract

Background: Advances in technology have made individual access to personal genetic information foreseeable in the near future. Policy makers and the media forecast that the ready availability of personal genetic profiles would benefit both the individual and the health care system by improving outcomes and decreasing cost. However, there is a significant gap between having access to genetic data and either wanting or understanding the information it provides.

Objective: Our primary aim was to evaluate, using a population-based sample of healthy adults, whether gender, race and education status influences interest and participation in a multiplex genetic susceptibility test.

Methods: Healthy, insured individuals, 25-40 years of age, were approached via a large, integrated health system in which primary and specialty care is available. Study participants were offered personalized genetic risk information on 8 common chronic health conditions. Social groups historically known not to participate in genetic research (men, African Americans and those from lower education neighborhoods) were oversampled. We describe the recruitment outcomes and testing decisions of these social groups.

Results: We found that even among those with access to health care, African Americans were less likely to participate in the multiplex genetic susceptibility test, while those from higher education neighborhoods were more likely to participate.

Conclusions: Our results suggest that large social groups will likely be underrepresented in research in personalized genomics even when robust population-based recruitment strategies are employed.

Citing Articles

Social vulnerability and genetic service utilization among unaffected BRIDGE trial patients with inherited cancer susceptibility.

Bather J, Goodman M, Harris A, Del Fiol G, Hess R, Wetter D BMC Cancer. 2025; 25(1):180.

PMID: 39891096 PMC: 11783932. DOI: 10.1186/s12885-025-13495-4.


The multigenerational impact of long QT syndrome: A Gitxsan perspective.

Huisman L, Martin S, Ewasiuk E, McAdam A, Wood Lynes-Ford K, McCormick R J Genet Couns. 2024; 34(1):e1927.

PMID: 38926912 PMC: 11735187. DOI: 10.1002/jgc4.1927.


Exploring the role of cancer fatalism and engagement with skin cancer genetic information in diverse primary care patients.

Hay J, Wu Y, Schofield E, Kaphingst K, Sussman A, Guest D Psychooncology. 2024; 33(4):e6331.

PMID: 38546209 PMC: 11391671. DOI: 10.1002/pon.6331.


Public Health Genomics: Time to Sharpen the Focus.

McBride C, Roberts J, Knerr S, Guan Y Public Health Genomics. 2023; 26(1):171-176.

PMID: 37729876 PMC: 10614505. DOI: 10.1159/000533985.


Autism spectrum disorder symptom expression in individuals with 3q29 deletion syndrome.

Pollak R, Pincus J, Burrell T, Cubells J, Klaiman C, Murphy M Mol Autism. 2022; 13(1):50.

PMID: 36566217 PMC: 9789637. DOI: 10.1186/s13229-022-00533-2.


References
1.
James R, Yu J, Henrikson N, Bowen D, Fullerton S . Strategies and stakeholders: minority recruitment in cancer genetics research. Community Genet. 2008; 11(4):241-9. DOI: 10.1159/000116878. View

2.
Khoury M, Gregory Feero W, Reyes M, Citrin T, Freedman A, Leonard D . The genomic applications in practice and prevention network. Genet Med. 2009; 11(7):488-94. PMC: 2743616. DOI: 10.1097/GIM.0b013e3181a551cc. View

3.
McBride C, Hensley Alford S, Reid R, Larson E, Baxevanis A, Brody L . Characteristics of users of online personalized genomic risk assessments: implications for physician-patient interactions. Genet Med. 2009; 11(8):582-7. PMC: 3341609. DOI: 10.1097/GIM.0b013e3181b22c3a. View

4.
Frazer K, Ballinger D, Cox D, Hinds D, Stuve L, Boudreau A . A second generation human haplotype map of over 3.1 million SNPs. Nature. 2007; 449(7164):851-61. PMC: 2689609. DOI: 10.1038/nature06258. View

5.
Hudson K, Holohan M, Collins F . Keeping pace with the times--the Genetic Information Nondiscrimination Act of 2008. N Engl J Med. 2008; 358(25):2661-3. DOI: 10.1056/NEJMp0803964. View